EU drug approval should include price evaluation, says expert panel
New drugs should not be approved for sale in the European Union (EU) unless pharmaceutical companies agree to a fair price, an expert panel has urged.Speaking at the European Public Health Alliance’s…
Read Original Article: EU drug approval should include price evaluation, says expert panel »
